Peripheral neuropathy decisions — 2025

The Board granted an initial rating of 40 percent for right and left lower extremity peripheral neuropathy, but denied higher ratings for the upper extremities. A TDIU was also granted prior to May 22, 2014.

The Board denied service connection for heart disease, DMII, prostate cancer, RLE and LLE peripheral neuropathy, and erectile dysfunction as they are not shown to be causally or etiologically related to any disease, injury, or incident during service.

The Board remands the claims for service connection for diabetes mellitus type II and peripheral neuropathy of both lower extremities, as additional evidence has been submitted that requires further medical evaluation.

The Veteran withdrew the appeals for higher ratings and service connection, resulting in their dismissal.

The Board found that the evidence did not support a finding that the Veteran's service-connected disabilities prevented him from securing or following substantially gainful employment as of September 15, 2022.

The Board denied the veteran's claims for increased ratings for various service-connected conditions and granted a total rating based on individual unemployability due to service-connected disability.

The Board denied the veteran's claims for a compensable rating for bilateral hearing loss, and dismissed his appeals for ratings in excess of 20 percent for diabetic peripheral neuropathy of both lower extremities and service connection for peripheral neuropathy of the upper extremities due to untimely notice of disagreement.

The Board of Veterans' Appeals remands the claims for service connection for various disabilities, including TBI residuals, seizures, psychiatric conditions, vertigo, sleep disorders, and neurological issues in the upper and lower extremities.

The Board remands the claims for service connection due to insufficient evidence and the need for further medical opinions.

The Board granted service connection for skin cancer, type II diabetes mellitus, hypertension, allergic rhinitis, and chronic sinusitis based on presumptive exposure to herbicides. Peripheral neuropathy of the right and left lower extremities was also granted due to their relationship with the Veteran's service-connected diabetes.

The Board denied higher ratings for the Veteran's compartment syndrome, superficial peroneal neuropathy of the left lower extremity with restless leg syndrome associated with compartment syndrome, and radiculopathy affecting both sciatic nerves. An earlier effective date was granted for the right sciatic nerve radiculopathy.

The Board remands the claims for further development, including obtaining outstanding medical records and scheduling new VA examinations.

The appeal was partially denied, with a separate noncompensable rating granted for headaches prior to March 21, 2023, and increased ratings denied for TBI with PTSD, dizziness, and mixed type headaches.

The veteran withdrew his appeal for service connection of bilateral lower extremities peripheral neuropathy, and the Board has no jurisdiction to review these issues.

The appeal was dismissed due to the Veteran's death during the pendency of the appeal.

The Board granted service connection for type II diabetes mellitus, multiple myeloma, and peripheral neuropathy of the bilateral upper and lower extremities based on in-service exposure to herbicide agents.

The Board granted an earlier effective date for diabetes mellitus type II and service connection for GERD, while denying increased ratings for lung cancer, hypertension, and hearing loss, among other issues.

The Board granted service connection for peripheral neuropathy of both lower extremities on a direct basis, resolving reasonable doubt in the Veteran's favor.

The Board vacated its February 12, 2025 decision and denied the veteran's claims for increased ratings and earlier effective dates.

The Board granted service connection for posttraumatic stress disorder (PTSD) and denied service connection for other psychiatric disorders, headaches, a left hip condition, hypothyroidism, right optic neuropathy, and obstructive sleep apnea.